SUVEN PHARMA ANALYSIS Target and SL intact.
Looking forward for hitting the target.
The dimond shape trade.
In Bears you need to find the Bulls.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
9.45 INR
3.00 B INR
10.36 B INR
101.49 M
About SUVEN PHARMACEUTICALS LTD
Sector
Industry
CEO
Sudhir Kumar Singh
Website
Headquarters
Hyderabad
Founded
2018
ISIN
INE03QK01018
FIGI
BBG00S6SV6M8
Suven Pharmaceuticals Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.
Suven Pharma Ltd view for Intraday 10th September #SUVENPHAR Suven Pharma Ltd view for Intraday 10th September #SUVENPHAR
Buying may witness above 1215
Support area 1200-1199. Below ignoring buying momentum for intraday
Selling may witness below 1199
Resistance area 1210-1215
Above ignoring selling momentum for intraday
Charts for Educational purposes onl
Suven Pharma Ltd view for Intraday 9th September #SUVENPHAR Suven Pharma Ltd view for Intraday 9th September #SUVENPHAR
Buying may witness above 1210
Support area 1190. Below ignoring buying momentum for intraday
Selling may witness below 1188
Resistance area 1210
Above ignoring selling momentum for intraday
Charts for Educational purposes only.
Please f
#SUVENPHAR NSE RANGE BREAKOUT DTF/WTF#SUVENPHAR NSE Has broken out of 31 week /8months Range to Close above 760, wait for Retest @775. Target's 900 ,950
go long - swing pick- this stock shows signficant delivery percentage value
- possible chances for accumulation
- may perform good in upcoming days
- this stock is picked after market close based on delivery qty data.
- follow this stock for next 5 days , if entry not triggered with in 5 days , ignore pick
- line ma
Suven Pharma on break out Something special is happening in the entire pharma sector, Sun Pharma is also at all time high and long positions have also been created in F&O in Cipla today. I think IT and pharma will lead now. And maybe suven pharma too Thank you.
Suven pharma can shine if it gets past the next resistance Suven Pharmaceuticals Ltd. is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under co
Suven pharmaCheck suven pharma entry level , it has come down to hunt liquidity sweep and fill Daily FGV.
Trade Idea in Suven Pharma
👋 Hey there! Ready to dive into the trading game? I'm your go-to Technical Analyst for some cool trade observations and trading wisdom. Just a heads up, my recommendations are all about learning and watching – no pressure to jump in. Let's break down those charts and turn them into some savvy tr
SUVENPHAR - Ichimoku BreakoutStock Name - Suven Pharmaceuticals Ltd
Ichimoku Cloud Setup :
1). Today's close is above the Conversion Line
2). Future Kumo is Turning Bullish
3). Chikou span is slanting upwards
All these parameters are showing bullishness at Current Market Price
and more bullishness AFTER crossing 723
#Thi
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SUVENPHAR is 1,287.70 INR — it has increased by 0.37% in the past 24 hours. Watch SUVEN PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SUVEN PHARMACEUTICALS LTD stocks are traded under the ticker SUVENPHAR.
SUVENPHAR stock has fallen by −1.63% compared to the previous week, the month change is a 7.58% rise, over the last year SUVEN PHARMACEUTICALS LTD has showed a 126.59% increase.
We've gathered analysts' opinions on SUVEN PHARMACEUTICALS LTD future price: according to them, SUVENPHAR price has a max estimate of 1,050.00 INR and a min estimate of 1,050.00 INR. Watch SUVENPHAR chart and read a more detailed SUVEN PHARMACEUTICALS LTD stock forecast: see what analysts think of SUVEN PHARMACEUTICALS LTD and suggest that you do with its stocks.
SUVENPHAR reached its all-time high on Nov 5, 2024 with the price of 1,353.95 INR, and its all-time low was 87.60 INR and was reached on Mar 24, 2020. View more price dynamics on SUVENPHAR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SUVENPHAR stock is 2.67% volatile and has beta coefficient of 0.55. Track SUVEN PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is SUVEN PHARMACEUTICALS LTD there?
Today SUVEN PHARMACEUTICALS LTD has the market capitalization of 327.13 B, it has increased by 0.83% over the last week.
Yes, you can track SUVEN PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
SUVEN PHARMACEUTICALS LTD is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
SUVENPHAR net income for the last quarter is 607.70 M INR, while the quarter before that showed 533.73 M INR of net income which accounts for 13.86% change. Track more SUVEN PHARMACEUTICALS LTD financial stats to get the full picture.
SUVEN PHARMACEUTICALS LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.21% and 6.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 1.05 K employees. See our rating of the largest employees — is SUVEN PHARMACEUTICALS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUVEN PHARMACEUTICALS LTD EBITDA is 3.16 B INR, and current EBITDA margin is 39.68%. See more stats in SUVEN PHARMACEUTICALS LTD financial statements.
Like other stocks, SUVENPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUVEN PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUVEN PHARMACEUTICALS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUVEN PHARMACEUTICALS LTD stock shows the buy signal. See more of SUVEN PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.